Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS-CoV2-specific Humoral and T-cell Immune Response After Second Vaccination in Liver Cirrhosis and Transplant Patients
Darius F. Ruether, Golda Schaub, Paul Duengelhoef, et al.
Clinical Gastroenterology and Hepatology (2021) Vol. 20, Iss. 1, pp. 162-172.e9
Open Access | Times Cited: 133

Showing 1-25 of 133 citing articles:

Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis
Ainsley Ryan Yan Bin Lee, Shi Yin Wong, Louis Yi Ann Chai, et al.
BMJ (2022), pp. e068632-e068632
Open Access | Times Cited: 390
Immunogenicity and Risk Factors Associated With Poor Humoral Immune Response of SARS-CoV-2 Vaccines in Recipients of Solid Organ Transplant
Kasama Manothummetha, Nipat Chuleerarux, Anawin Sanguankeo, et al.
JAMA Network Open (2022) Vol. 5, Iss. 4, pp. e226822-e226822
Open Access | Times Cited: 87
Safety and antibody response to inactivated COVID‐19 vaccine in patients with chronic hepatitis B virus infection
Taiyu He, Yingzhi Zhou, Pan Xu, et al.
Liver International (2022) Vol. 42, Iss. 6, pp. 1287-1296
Closed Access | Times Cited: 46
Immunogenicity of COVID-19 vaccines in solid organ transplant recipients: a systematic review and meta-analysis
Xinpei Chen, De Luo, Bingjie Mei, et al.
Clinical Microbiology and Infection (2022) Vol. 29, Iss. 4, pp. 441-456
Open Access | Times Cited: 44
COVID-19-associated liver injury: Clinical characteristics, pathophysiological mechanisms and treatment management
Penghui Li, Ying Liu, Ziqi Cheng, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 154, pp. 113568-113568
Open Access | Times Cited: 42
Patients with Liver Cirrhosis Show High Immunogenicity upon COVID-19 Vaccination but Develop Premature Deterioration of Antibody Titers
Katharina Willuweit, Alexandra Frey, Moritz Passenberg, et al.
Vaccines (2022) Vol. 10, Iss. 3, pp. 377-377
Open Access | Times Cited: 39
A third dose of the BNT162b2 mRNA vaccine significantly improves immune responses among liver transplant recipients
Yana Davidov, Victoria Indenbaum, Keren Tsaraf, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 3, pp. 702-709
Open Access | Times Cited: 39
Involvement of the Liver in COVID-19: A Systematic Review
Jayani Kariyawasam, Umesh Jayarajah, Visula Abeysuriya, et al.
American Journal of Tropical Medicine and Hygiene (2022) Vol. 106, Iss. 4, pp. 1026-1041
Open Access | Times Cited: 38
COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: A meta-analysis
Ka Shing Cheung, Chiu Hang Mok, Xianhua Mao, et al.
Clinical and Molecular Hepatology (2022) Vol. 28, Iss. 4, pp. 890-911
Open Access | Times Cited: 37
Advancements in Vaccine Strategies for Chronic Liver Disease Patients: Navigating Post-COVID Challenges and Opportunities
Samer Al-Dury, Nelly Kanberg
Vaccines (2024) Vol. 12, Iss. 2, pp. 197-197
Open Access | Times Cited: 10
Coordinated cellular and humoral immune responses after two‐dose SARS‐CoV2 mRNA vaccination in liver transplant recipients
Gianpiero D’Offizi, Chiara Agrati, Ubaldo Visco‐Comandini, et al.
Liver International (2021) Vol. 42, Iss. 1, pp. 180-186
Open Access | Times Cited: 41
SARS‐CoV‐2 vaccination response in patients with autoimmune hepatitis and autoimmune cholestatic liver disease
Paul Duengelhoef, Johannes Hartl, Darius F. Rüther, et al.
United European Gastroenterology Journal (2022) Vol. 10, Iss. 3, pp. 319-329
Open Access | Times Cited: 35
Humoral and Cellular Immune Response After Third and Fourth SARS-CoV-2 mRNA Vaccination in Liver Transplant Recipients
Aenne Harberts, Golda Schaub, Darius F. Ruether, et al.
Clinical Gastroenterology and Hepatology (2022) Vol. 20, Iss. 11, pp. 2558-2566.e5
Open Access | Times Cited: 35
Past COVID-19 and immunosuppressive regimens affect the long-term response to anti-SARS-CoV-2 vaccination in liver transplant recipients
Pierluigi Toniutto, Edmondo Falleti, Sara Cmet, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 1, pp. 152-162
Open Access | Times Cited: 32
Factors Associated With COVID-19 Vaccine Response in Transplant Recipients: A Systematic Review and Meta-analysis
Jiajing Li, Ibrahim Ayada, Yining Wang, et al.
Transplantation (2022) Vol. 106, Iss. 10, pp. 2068-2075
Open Access | Times Cited: 32
Third dose of COVID-19 mRNA vaccine appears to overcome vaccine hyporesponsiveness in patients with cirrhosis
Binu V. John, Raphaella Ferreira, Akash Doshi, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 5, pp. 1349-1358
Open Access | Times Cited: 32
Humoral and cellular response of COVID‐19 vaccine among solid organ transplant recipients: A systematic review and meta‐analysis
Hari Shankar Meshram, Vivek Kute, Hemant Rane, et al.
Transplant Infectious Disease (2022) Vol. 24, Iss. 6
Open Access | Times Cited: 30
Mycophenolate mofetil decreases humoral responses to three doses of SARS‐CoV‐2 vaccine in liver transplant recipients
Lucy Meunier, Mathilde Sanavio, Jérôme Dumortier, et al.
Liver International (2022) Vol. 42, Iss. 8, pp. 1872-1878
Open Access | Times Cited: 27
Prediction of humoral and cellular immune response to COVID-19 mRNA vaccination by TTV load in kidney transplant recipients and hemodialysis patients
Marianne Graninger, Julian Stumpf, Gregor Bond, et al.
Journal of Clinical Virology (2023) Vol. 162, pp. 105428-105428
Open Access | Times Cited: 16
Autoimmune hepatitis under the COVID-19 veil: an analysis of the nature of potential associations
Chaojie Yu, Wenrui Wang, Qian Zhang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Humoral Immune Response following SARS-CoV-2 Vaccination in Liver Transplant Recipients
Lea Timmermann, Brigitta Globke, Georg Lurje, et al.
Vaccines (2021) Vol. 9, Iss. 12, pp. 1422-1422
Open Access | Times Cited: 35
Humoral Response to 2-dose BNT162b2 mRNA COVID-19 Vaccination in Liver Transplant Recipients
Maria Guarino, Ilaria Esposito, Giuseppe Portella, et al.
Clinical Gastroenterology and Hepatology (2022) Vol. 20, Iss. 7, pp. 1534-1541.e4
Open Access | Times Cited: 24
Immunogenicity and safety of a third dose of anti‐SARS‐CoV‐2 BNT16b2 vaccine in liver transplant recipients
Pierluigi Toniutto, Annarosa Cussigh, Sara Cmet, et al.
Liver International (2022) Vol. 43, Iss. 2, pp. 452-461
Open Access | Times Cited: 23
Impaired SARS-CoV-2-specific T-cell reactivity in patients with cirrhosis following mRNA COVID-19 vaccination
Samer Al-Dury, Johan Waern, J. Waldenström, et al.
JHEP Reports (2022) Vol. 4, Iss. 7, pp. 100496-100496
Open Access | Times Cited: 22
COVID-19 Vaccination in Patients with Chronic Liver Disease
Georgios Schinas, Eleni Polyzou, Fevronia Mitropetrou, et al.
Viruses (2022) Vol. 14, Iss. 12, pp. 2778-2778
Open Access | Times Cited: 22
Page 1 - Next Page

Scroll to top